Vimentin antibody production in transplant patients and immunomodulatory effects of vimentin in-vitro

Human Immunology

Volumn 74, Issue 11, 2013, Pages 1463-1469

  Carter, Vaughan ^a   Howell, W Martin ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; HLA ANTIBODY; HLA DQ2 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEPATITIS; BRONCHIECTASIS; CARDIOMYOPATHY; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; FEMALE; GLOMERULONEPHRITIS; GRAFT FAILURE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOREGULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY POLYCYSTIC DISEASE; LIVER CIRRHOSIS; LIVER FAILURE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PYELONEPHRITIS; SCHOOL CHILD; TH2 CELL; TRANSPLANTATION;

ANTIGEN PRESENTING CELLS; APCS; HLA; HUMAN LEUKOCYTE ANTIGEN; IG; IL; IMMUNOGLOBULIN; INTERLEUKIN; MHC CLASS I RELATED CHAIN; MIC; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHA; PHYTOHAEMAGGLUTININ; T HELPER T CELL; TH;

ADOLESCENT; ADULT; AGED; ANTIBODIES; ANTIBODY FORMATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HLA-DQ ANTIGENS; HUMANS; IMMUNOMODULATION; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; LIVER FAILURE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; REOPERATION; VIMENTIN; YOUNG ADULT;

EID: 84885039979     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.06.014     Document Type: Article

References (28)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 2003, 6:665-673.
2. Mengel M., Sis B., Haas M., Colvin R.B., Halloran P.F., Racusen L.C., et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012, 3:563-570.
3. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365:1570-1576.
4. Zou Y., Stastny P., Su{double acute}sal C., Döhler B., Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007, 357:1293-1300.
5. Dragun D., Catar R., Kusch A., Heidecke A., Phillipe H. Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection. Hum Immunol 2012, 73:1282-1286.
6. Carter V., Shenton B.K., Jaques B., Turner D., Talbot D., Gupta A., et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Trans. Proc. 2005, 37:654-657.
7. Pallet N., Dieudé M., Cailhier J., Hébert M. The molecular legacy of apoptosis in transplantation. Am J Transplant 2012, 6:1378-1384.
8. Sumpter T.L., Roberts T.J., Wilkes D.S. Interface between alloimmunity and autoimmunity. Curr Opin Organ Transplant 2004, 9:23-28.
9. Haque M.A., Mizobuchi T., Yasufuku K., Fujisawa T., Brutiewicz R.R., Zheng Y., et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002, 169:1542-1549.
10. Rolls H.K., Kishimoto K., Dong V.M., Illigens B.M., Sho M., Sayegh M.H., et al. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation 2002, 74:1053-1057.
11. Barber L.D., Whitelegg A., Madrigal J.A., Banner N.R., Rose M.L. Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation 2004, 77:1604-1609.
12. Hachem R.R., Tiriveedhi V., Patterson G.A., Aloush A., Trulock E.P., Mohanakumar T. Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012, 12:2164-2171.
13. Yaoita E., Franke W.W., Yamamoto T., Kawasaki K., Kihara I. Identification of renal podocytes in multiple species: higher vertebrates are vimentin positive/lower vertebrates are desmin positive. Histochem Cell Biol 1999, 111:107-115.
14. Fuchs E., Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994, 63:345-382.
15. Boilard E., Bourgoin S.G., Bernatchez C., Surette M.E. Identification of an autoantigen on the surface of apoptotic human T cells as new protein interacting with inflammatory group IIA phospholipase A2. Blood 2001, 102:2901-2909.
16. Jurcevic S., Ainsworth M.E., Pomerance A., Smith J.D., Robinson D.R., Dunn M.J., et al. Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001, 71:886-892.
17. Rose M.L. Non-HLA antibodies and the role of the autoimmune response in transplant rejection. Curr Opin Transplant 2006, 11:439-443.
18. Kurki P., Miettinen A., Salaspuro M., Virtanen N., Stenman S. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. Hepatology 1983, 3(b):297-302.
19. Susskind B. Hyperacute rejection of a 000 mismatched kidney. Hum Immunol 2003, 64:563.
20. Sun Q., Cheng Z., Cheng D., Chen J., Ji S., Wen J., et al. De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int 2011, 79(6):655-662.
21. Ju{double acute}se U., van de Wal Y., Koning F., Sollid L.M., Fleckenstein B. Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library. Hum Immunol 2010, 71:475-481.
22. Jackson A.M., Kuperman M.B., Montgomery R.A. Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. Am J Transplant 2012, 12:1643-1649.
23. Kamradt T., Mitchison N.A. Tolerance and autoimmunity. N Engl J Med 2001, 344:655-664.
24. Komagata Y., Weiner H.L. Oral tolerance. Rev Immunogenet 2000, 2:61-73.
25. Opelz G., Graver B., Terasaki P.I. Induction of high kidney graft survival rate by multiple transfusion. Lancet 1981, 8232:1223-1225.
26. Belperio J.A., Keane M.P., Strieter R.M. Cytokines during the pathogenesis of Bronchiolitis obliterans syndrome. Curr Opin Organ Transplant 2003, 8:228-238.
27. Punnonen J., Aversa G., de Vries J.E. Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+T cells or their membranes. Blood 1993, 82:2781-2789.
28. Muramatsu M., Miyagi M., Ishikawa Y., Aikawa A., Mizuiri S., Ohara T., et al. Estimation of damaged tubular epithelium in renal allografts determination of vimentin expression. Int J Urol 2004, 11:954-962.